PATH supports public policies for patients, providers and payers to realize the benefits of artificial intelligence, automation, and robotics based on the following principles:
- Improving patient outcomes is the core objective for all of PATH’s activities and believes that expanded uses of these newer technologies will enhance health care delivery.
- The use of these technologies should be evaluated in validated, peer-reviewed clinical trials based on their ability to 1) identify illness at its earliest stage; 2) facilitate access to appropriate care; 3) reduce the per unit cost of care; and 4) significantly reduce misdiagnoses and medical errors. PATH will identify priorities for such evaluative research and development. help
- Benefits of these technologies may not accrue uniformly, and disruptions will inevitably occur. Market opportunities will allow new entrants to emerge and increase competition among existing institutions. However, the priority should remain on improved care, expanded access and lowered expenditures, rather than protecting any status quo.
- These technologies can provide benefits to existing healthcare institutions but equally important, they can help overcome the overwhelming needs of less served populations around the world.
- Appropriate regulation of these technologies is critical to provide assurances of quality and to guard against abuse such as standards for privacy and data security as well as for the safety, effectiveness, and accessibility of services. For example, PATH supports expansion of the digital health pre-certification program of the U.S. Food and Drug Administration as well as similar efforts in other countries. However, arbitrary regulatory or professional barriers that only serve to thwart progress or competition must be rejected.
- PATH will work with academia, health providers, public and private third-party payors and providers to achieve appropriate payment policies that reflect the unique value-added of artificial intelligence, automation, and robotics tools. One approach is new coding to reflect new procedures based on these new technologies such as AMA’s new CPT code for inter-professional internet-based interprofessional consultation services provided by a consultative physician. This may also require a different payment approach and levels of payment than currently used for reimbursement of services. We recognize that the financial incentives of value-based payments are more conducive to the use these tools than the perverse incentives of fee-for-service reimbursement.
- PATH is committed to developing public goodwill for artificial intelligence, automation, and robotics, promoting analysis, and identifying and publicizing best practices. As such, PATH is committed to informing patients, providers, payors, regulators, and other governmental and professional bodies about the value and uses of artificial intelligence, automation, and robotics as well as listening to their views. Development of public policies, clinical standards, practice guidelines should involve all stakeholders.